A Health Economic Evaluation for Implementing an Extended Half-life Monoclonal Antibody for All Infants vs. Standard Care for Respiratory Virus Syncytial Prophylaxis in Canada

Thomas Shin, Jason KH Lee, Alexia Kieffer, Michael Greenberg, Jianhong Wu
doi: https://doi.org/10.1101/2024.03.28.24305020

Article usage

Article usage: March 2024 to December 2024

AbstractFullPdf
Mar 2024442032
Apr 202421217051
May 2024818721
Jun 2024461914
Jul 2024471624
Aug 2024501714
Sep 2024322514
Oct 2024352010
Nov 2024401619
Dec 2024101812
Back to top
Posted March 28, 2024.
Download PDF
Data/Code
Email
A Health Economic Evaluation for Implementing an Extended Half-life Monoclonal Antibody for All Infants vs. Standard Care for Respiratory Virus Syncytial Prophylaxis in Canada
Thomas Shin, Jason KH Lee, Alexia Kieffer, Michael Greenberg, Jianhong Wu
medRxiv 2024.03.28.24305020; doi: https://doi.org/10.1101/2024.03.28.24305020
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area